Mottola Frank bought SUPN
August 25, 2025 · Form 4 insider transaction
Mottola Frank bought 14,000 shares of Supernus Pharmaceuticals, Inc. at $12.98 per share, a transaction worth $181.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,000
Price
$12.98
Total value
$181.7K
InsiderMottola Frank
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 25, 2025
Filing dateAugust 27, 2025
Shares owned after29,496
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes an aggregate of 345 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.